October 6, 2025 (Washington, DC)—The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation (ATF), today announced that the Ann Theodore Foundation Breakthrough Sarcoidosis Initiative (ATF-BSI) has awarded five grants totaling more than $2.5 million to interdisciplinary research teams. Concurrently, the two partners have launched ATF-BSI’s fifth round of philanthropic funding via a new request for proposals (RFP) related to sarcoidosis research.
ATF-BSI’s fourth cohort of awardees spans five funded projects (listed below). Each project is associated with an institution with which the project’s lead investigator is affiliated. Some funded projects include investigators and researchers at additional institutions.
ATF and SPARC also invite independent researchers who are interested in conducting research in sarcoidosis or other granulomatous diseases to explore the new RFP for an upcoming round of funding to be announced mid-year 2026. One-page letters of intent will be accepted through 11:59 p.m. ET on Thursday, October 23, 2025. Funded projects will be eligible for up to $460,000 in funding over two years, and funded projects tied to interdisciplinary research teams will be eligible for up to $575,000 over two years. Potential applicants are encouraged to submit letters of intent regardless of whether they have prior experience in sarcoidosis-specific experience; applicants without experience in sarcoidosis are not required to co-apply with a sarcoidosis expert to qualify for funding.
Sarcoidosis, a debilitating and sometimes fatal inflammatory condition, is marked by abnormal clusters of immune cells in various organs—most frequently in the lungs. In the absence of a cure or even disease-specific treatments, people living with sarcoidosis may experience extreme fatigue, breathing difficulties, joint pain, fever, or eye inflammation. These complications may resolve spontaneously in one to two years for some individuals, while they may be lifelong or recurrent for others.
Due to historically meager funding for sarcoidosis research, few clinicians and researchers study the disease. To change that, ATF and SPARC have partnered since 2020. Among other efforts, they have published a Giving Smarter Guide that identifies strategic opportunities for philanthropic investment in sarcoidosis and launched ATF-BSI, which has since committed over $10 million to sarcoidosis research. To date, more than 20 teams from over 15 institutions have used ATF-BSI’s funding to initiate research aimed at advancing understanding of sarcoidosis’ underlying biology, which is needed to develop novel, effective therapeutics.
“Achieving better treatment and care for sarcoidosis isn’t explained by a lack of scientific interest or by the nature of the disease itself—it’s been limited by insufficient resources and field organization,” said Cara Altimus, PhD, managing director of SPARC. “As each new cohort of funded researchers receives the support they need, we’re proud not only to activate promising research directions but also to grow the nascent community of scientists and clinicians who can build shared knowledge, create resources for the field, and train an upcoming generation of researchers to enable continuous progress for years to come. We believe that better treatments are in sight.”
“With so much about sarcoidosis remaining a mystery—why so many people experience different symptoms of varying severity, sometimes temporarily and sometimes permanently—the medical community is limited in the treatment they can offer,” said Lisa Spalding, spokesperson for the Ann Theodore Foundation. “We must meet this moment by supporting those who seek to answer those questions, as a necessary step toward treating the roots of this debilitating illness.”
Sam Roth
[email protected]
The Milken Institute is a nonprofit, nonpartisan think tank focused on accelerating measurable progress on the path to a meaningful life. With a focus on financial, physical, mental, and environmental health, we bring together the best ideas and innovative resourcing to develop blueprints for tackling some of our most critical global issues through the lens of what’s pressing now and what’s coming next.
Milken Institute Strategic Philanthropy tackles persistent societal challenges by guiding individuals and foundations with the insights and tools to develop strategies, implement giving programs, and foster collaboration to create a better, more equitable world.
The Milken Institute’s Science Philanthropy Accelerator for Research and Collaboration (SPARC) works to develop, launch, and lead initiatives that fund medical research and invest to accelerate the development of tools and treatments that will bring better health to millions of people. We partner with philanthropists, leading them through complex medical research and clinical systems.
The Ann Theodore Foundation is a grant-making private foundation that supports a broad range of initiatives, including opportunities for learning and enrichment for young people, food security, climate change mitigation, college access and success, and research towards a cure and improving care for people with sarcoidosis. The Foundation’s philanthropy is informed by the values of compassion, integrity, respect, and community.
